Research shows bad dreams could predict future memory and thinking problems
Researchers in Portugal have discovered that the content of dreams, particularly those with negative emotions, may predict long-term cognitive decline in people with Parkinson’s.
Link found between diabetes and increased Parkinson’s risk
An international team of researchers have uncovered a biological link that may account for why those with diabetes have a higher risk of developing Parkinson’s.
Biogen step in to take forward promising gene-based drugs for Parkinson’s
Major pharmaceutical company Biogen is investing $1billion to take LRRK2 inhibitors into large scale clinical trials in 2021.
Parkinson’s UK commit further funding to develop drugs that protect mitochondria
We’re investing a further £1 million to drive forward drugs that target energy-producing mitochondria to slow the loss of brain cells in Parkinson's.
Help researchers adapt their studies
Researchers are taking steps to invite people back to take part in face-to-face studies. To help them make sure their research resumes in a safe, practical, and convenient way, we'd like you to take part in a survey.
How have coronavirus (COVID-19) restrictions impacted people affected by Parkinson’s?
With Lancaster University, we conducted a survey that shows the coronavirus restrictions are having a big impact on the lives and the health of people affected by Parkinson’s.
Protecting the future of research after coronavirus (COVID-19)
Medical research charities have come together and are asking the government to act now and set up a fund to ensure that the future of charity-funded research is protected
Replacing cells lost in Parkinson’s
New one-step process converts cells inside the brain into dopamine-producing cells to replace those lost in Parkinson's.
Help researchers understand coronavirus
New opportunities to take part in research have been added to the Take Part Hub, including studies specifically looking to gather people's experiences of social isolation.